NASDAQ : IDYA
IDEAYA Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 32.89 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.17B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
IDEAYA Biosciences, Inc. (IDYA) reported revenue of 234.13M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 234.13M | 218.71M | 7.00M | 23.39M | 50.93M | 27.94M |
| Cost of Revenue | 374.01M | 314.70M | 294.67M | 129.51M | 89.54M | 58.16M |
| Gross Profit | -139.88M | -95.99M | -287.67M | -106.12M | -38.60M | -30.22M |
| Selling, General & Admin | 77.07M | 63.32M | 39.30M | 28.31M | 23.90M | 20.05M |
| Operating Expenses | 77.07M | 63.32M | 39.30M | 28.31M | 23.90M | 20.05M |
| Operating Income | -216.95M | -159.31M | -326.98M | -134.43M | -62.50M | -50.27M |
| Interest & Investment Income | 31.96M | 35.64M | 29.27M | 9.91M | 3.15M | 2.34M |
| EBT Excluding Unusual Items | -185.00M | -123.67M | -297.71M | -124.51M | -59.35M | -47.93M |
| Gain (Loss) on Sale of Investments | 9.98M | 9.98M | 23.23M | 11.55M | 695.00K | -1.83M |
| Pretax Income | -175.02M | -113.70M | -274.48M | -112.96M | -58.66M | -49.76M |
| Net Income | -175.02M | -113.70M | -274.48M | -112.96M | -58.66M | -49.76M |
| Net Income to Common | -175.02M | -113.70M | -274.48M | -112.96M | -58.66M | -49.76M |
| Shares Outstanding (Basic) | 89.47M | 88.49M | 81.68M | 57.52M | 41.44M | 35.25M |
| Shares Outstanding (Diluted) | 89.47M | 88.49M | 81.68M | 57.52M | 41.44M | 35.25M |
| EPS (Basic) | -1.96 | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 |
| EPS (Diluted) | -1.96 | -1.28 | -3.36 | -1.96 | -1.42 | -1.41 |
| Free Cash Flow | -113.87M | -73.47M | -251.44M | -117.59M | -90.62M | -58.42M |
| Free Cash Flow Per Share | -1.27 | -0.83 | -3.08 | -2.04 | -2.19 | -1.66 |
| Gross Margin | -59.75% | -43.89% | -75.80% | -108.15% | ||
| Operating Margin | -92.66% | -72.84% | -4,671.07% | -574.85% | -122.72% | -179.91% |
| Profit Margin | -74.75% | -51.99% | -3,921.10% | -483.05% | -115.17% | -178.10% |
| Free Cash Flow Margin | -48.64% | -33.59% | -3,592.01% | -502.85% | -177.92% | -209.09% |
| EBITDA | -214.19M | -156.61M | -324.59M | -131.95M | -60.40M | -48.54M |
| EBITDA Margin | -91.49% | -71.61% | -118.59% | -173.73% | ||
| D&A For EBITDA | 2.76M | 2.70M | 2.39M | 2.48M | 2.10M | 1.73M |
| EBIT | -216.95M | -159.31M | -326.98M | -134.43M | -62.50M | -50.27M |
| EBIT Margin | -92.66% | -72.84% | -122.72% | -179.91% | ||
| Revenue as Reported | 234.13M | 218.71M | 7.00M | 23.39M | 50.93M | 27.94M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 272.59M | 112.83M | 84.38M | 157.02M | 68.63M | 92.05M |
| Short-Term Investments | 556.37M | 526.56M | 591.94M | 368.10M | 296.20M | 154.72M |
| Cash & Short-Term Investments | 828.96M | 639.39M | 676.32M | 525.11M | 364.83M | 246.77M |
| Receivables | 15.42M | 5.97M | 18.00K | 211.00K | 1.10M | |
| Prepaid Expenses | 19.65M | 21.37M | 13.39M | 7.50M | 5.41M | 3.12M |
| Total Current Assets | 864.02M | 666.73M | 689.71M | 532.63M | 370.45M | 251.00M |
| Property, Plant & Equipment | 30.46M | 31.29M | 27.74M | 8.41M | 8.99M | 8.66M |
| Long-Term Investments | 413.93M | 410.30M | 405.83M | 107.49M | 8.32M | 121.29M |
| Other Long-Term Assets | 1.28M | 1.01M | 805.00K | 782.00K | 205.00K | 397.00K |
| Total Assets | 1.31B | 1.11B | 1.12B | 649.32M | 387.97M | 381.35M |
| Accounts Payable | 30.51M | 17.58M | 15.42M | 6.60M | 4.28M | 2.10M |
| Accrued Expenses | 50.98M | 40.89M | 30.35M | 18.76M | 17.00M | 12.32M |
| Current Portion of Leases | 1.19M | 339.00K | 298.00K | 1.75M | 1.87M | 1.70M |
| Current Unearned Revenue | 8.57M | 29.04M | ||||
| Total Current Liabilities | 82.68M | 58.81M | 46.07M | 27.10M | 31.72M | 45.16M |
| Long-Term Leases | 28.12M | 27.57M | 18.87M | 1.12M | 1.61M | 3.48M |
| Long-Term Unearned Revenue | 5.18M | 31.19M | ||||
| Total Liabilities | 110.79M | 86.39M | 64.94M | 28.23M | 38.51M | 79.83M |
| Common Stock | 10.00K | 9.00K | 9.00K | 7.00K | 5.00K | 4.00K |
| Additional Paid-In Capital | 2.15B | 1.76B | 1.68B | 968.88M | 587.72M | 478.97M |
| Retained Earnings | -947.53M | -736.54M | -622.84M | -348.36M | -235.40M | -176.75M |
| Comprehensive Income & Other | -1.67M | 2.27M | 812.00K | 562.00K | -2.87M | -712.00K |
| Total Common Equity | 1.20B | 1.02B | 1.06B | 621.09M | 349.45M | 301.51M |
| Shareholders' Equity | 1.20B | 1.02B | 1.06B | 621.09M | 349.45M | 301.51M |
| Total Liabilities & Equity | 1.31B | 1.11B | 1.12B | 649.32M | 387.97M | 381.35M |
| Total Debt | 29.31M | 27.91M | 19.17M | 2.87M | 3.48M | 5.18M |
| Net Cash (Debt) | 1.21B | 1.02B | 1.06B | 629.73M | 369.66M | 362.88M |
| Net Cash Per Share | 13.56 | 11.55 | 13.01 | 10.95 | 8.92 | 10.29 |
| Filing Date Shares Outstanding | 96.49M | 87.81M | 87.54M | 74.56M | 48.39M | 38.63M |
| Total Common Shares Outstanding | 96.38M | 87.80M | 86.50M | 65.04M | 48.19M | 38.53M |
| Working Capital | 781.35M | 607.91M | 643.64M | 505.53M | 338.74M | 205.84M |
| Book Value Per Share | 12.44 | 11.65 | 12.24 | 9.55 | 7.25 | 7.82 |
| Tangible Book Value | 1.20B | 1.02B | 1.06B | 621.09M | 349.45M | 301.51M |
| Tangible Book Value Per Share | 12.44 | 11.65 | 12.24 | 9.55 | 7.25 | 7.82 |
| Machinery | 18.43M | 17.08M | 15.53M | 12.22M | 10.51M | 7.02M |
| Leasehold Improvements | 5.17M | 5.12M | 4.91M | 3.32M | 3.32M | 3.13M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -175.02M | -113.70M | -274.48M | -112.96M | -58.66M | -49.76M |
| Depreciation & Amortization | 4.49M | 4.59M | 3.83M | 4.01M | 3.52M | 3.03M |
| Loss (Gain) From Sale of Investments | -5.74M | -9.98M | -23.23M | -11.55M | -695.00K | 1.83M |
| Stock-Based Compensation | 55.20M | 46.12M | 34.75M | 18.49M | 11.63M | 8.24M |
| Change in Accounts Receivable | -15.42M | -5.97M | -13.56M | 892.00K | 774.00K | |
| Change in Accounts Payable | 12.27M | 2.70M | 8.28M | 2.63M | 1.86M | 1.17M |
| Change in Unearned Revenue | -46.48M | -23.54M | ||||
| Change in Other Net Operating Assets | 12.54M | 5.14M | 3.27M | -2.28M | 754.00K | 2.48M |
| Operating Cash Flow | -111.66M | -71.10M | -247.58M | -115.22M | -87.17M | -55.78M |
| Capital Expenditures | -2.21M | -2.37M | -3.86M | -2.37M | -3.44M | -2.64M |
| Investment in Securities | -90.53M | 72.34M | -498.70M | -156.09M | -29.96M | -67.02M |
| Investing Cash Flow | -92.74M | 69.98M | -502.56M | -158.46M | -33.40M | -69.67M |
| Issuance of Common Stock | 221.82M | 29.78M | 668.15M | 320.54M | 97.17M | 145.45M |
| Other Financing Activities | 141.00M | 9.40M | 42.18M | |||
| Financing Cash Flow | 362.82M | 29.78M | 677.55M | 362.72M | 97.17M | 145.45M |
| Net Cash Flow | 158.42M | 28.66M | -72.59M | 89.04M | -23.41M | 20.01M |
| Free Cash Flow | -113.87M | -73.47M | -251.44M | -117.59M | -90.62M | -58.42M |
| Free Cash Flow Margin | -48.64% | -33.59% | -3,592.01% | -502.85% | -177.92% | -209.09% |
| Free Cash Flow Per Share | -1.27 | -0.83 | -3.08 | -2.04 | -2.19 | -1.66 |
| Levered Free Cash Flow | -70.85M | -52.47M | -155.09M | -70.28M | -42.37M | -15.64M |
| Unlevered Free Cash Flow | -70.85M | -52.47M | -155.09M | -70.28M | -42.37M | -15.64M |
| Cash Interest Paid | 25.00K | 69.00K | 60.00K | 71.00K | ||
| Cash Income Tax Paid | 4.00K | |||||
| Change in Working Capital | 9.40M | 1.87M | 11.55M | -13.21M | -42.97M | -19.12M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.08B | 3.03B | 2.22B | 2.29B | 874.22M | 909.90M |
| Enterprise Value | 1.87B | 1.92B | 1.04B | 1.78B | 484.21M | 529.72M |
| Last Close Price | 31.96 | 34.57 | 25.70 | 35.58 | 18.17 | 23.64 |
| Forward PE | 68.36 | 68.36 | 68.36 | 68.36 | 68.36 | |
| PS Ratio | 13.17 | 13.86 | 317.33 | 98.07 | 17.16 | 32.56 |
| PB Ratio | 2.57 | 2.96 | 2.10 | 3.69 | 2.50 | 3.02 |
| P/TBV Ratio | 2.57 | 2.96 | 2.10 | 3.69 | 2.50 | 3.02 |
| EV/Sales Ratio | 7.99 | 8.78 | 148.56 | 76.31 | 9.51 | 18.96 |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 |
| Net Debt / Equity Ratio | -1.01 | -1.00 | -1.00 | -1.01 | -1.06 | -1.20 |
| Net Debt / EBITDA Ratio | 5.67 | 6.52 | 3.27 | 4.77 | 6.12 | 7.47 |
| Net Debt / FCF Ratio | 10.66 | 13.91 | 4.23 | 5.36 | 4.08 | 6.21 |
| Asset Turnover | 0.20 | 0.20 | 0.01 | 0.04 | 0.13 | 0.08 |
| Quick Ratio | 10.21 | 10.97 | 14.68 | 19.38 | 11.51 | 5.49 |
| Current Ratio | 10.45 | 11.34 | 14.97 | 19.65 | 11.68 | 5.56 |
| Return on Equity (ROE) | -16.22% | -10.92% | -32.67% | -23.28% | -18.02% | -19.91% |
| Return on Assets (ROA) | -11.54% | -8.92% | -23.05% | -16.20% | -10.15% | -9.25% |
| Return on Capital Employed (ROCE) | -17.70% | -15.20% | -30.30% | -21.60% | -17.50% | -15.00% |
| Earnings Yield | -6.12% | -3.75% | -12.36% | -4.92% | -6.71% | -5.47% |
| FCF Yield | -3.69% | -2.42% | -11.32% | -5.13% | -10.37% | -6.42% |
| Buyback Yield / Dilution | -2.12% | -8.33% | -42.00% | -38.79% | -17.57% | -42.60% |